Federal Register of Legislation - Australian Government

Primary content

PB 4 of 2018 Other as made
This instrument amends Schedule 1 to the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).
Administered by: Health
Made 22 Jan 2018
Registered 24 Jan 2018
Tabled HR 05 Feb 2018
Tabled Senate 05 Feb 2018
Date of repeal 02 Feb 2018
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 4 of 2018

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)

National Health Act 1953

 

 

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         22 January 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

___________________________________________________________________________

 

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)           This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2018 (No. 1)

(2)           This Instrument may also be cited as PB 4 of 2018.

2          Commencement

This Instrument commences on 1 February 2018.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                           


Schedule 1        Amendments

 

[1]           Schedule 1, omit entry for Cyproheptadine

[2]           Schedule 1, after entry for Raloxifene

insert:

Raltegravir

Tablet 600 mg (as potassium)

20

120

5

 

[3]           Schedule 1

omit:

Testosterone

Injection containing testosterone enanthate 250 mg in 1 mL

20

3

3